INDV

Indivior Pharmaceuticals Stock Analysis

AI Rating

Neutral
  • Quality0/10
  • Growth↑ 9/10
  • Value↑ 5/10
Indivior Pharmaceuticals sales and earnings growth
INDV Growth
Great
  • Revenue Y/Y↓ 4.29%
  • EPS Y/Y↑ 3260.00%
  • FCF Y/Y↓ -1428.57%
Indivior Pharmaceuticals gross and profit margin trends
INDV Profitability
Good
  • Gross margin ↑ 80.10%
  • EPS margin↑ 16.90%
  • ROIC 5Y↑ 0.00%
Indivior Pharmaceuticals net debt vs free cash flow
INDV Risk
Poor
  • Debt / Equity↑ 999.0
  • Debt / FCF↓ 1.7
  • Interest coverage↑ 6.3

Indivior Pharmaceuticals stock is less volatile than the overall market, so it's low risk. We give it a Poor risk rating.

More Drug Manufacturers - Specialty & Generic stocks ↗